Ajim Tamboli

Ajim Tamboli

No open positions remaining
49 year
Finance
Health Technology
Consumer Services

Profile

Ajim Akbar Tamboli is currently Chief Financial Officer at First Tracks Biotherapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at Monte Rosa Therapeutics, Inc. from 2020 to 2023, at Rodin Therapeutics, Inc. from 2019 to 2020, and at ADARx Pharmaceuticals, Inc. Held the position of Analyst at Asymmetry Capital Management LP from 2018 to 2019 and at Columbia Management Investment Advisers LLC from 2010 to 2013.
Worked as Senior Portfolio Manager at Hovan Capital Management LLC from 2008 to 2009.
Was Research Analyst at Lehman Brothers, Inc. from 2003 to 2007 and Consultant at Duquesne Capital Management LLC in 2002.
Served as Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2000 to 2001.
Also held the role of Partner & Analyst at Endurant Capital Management LP.
Education includes undergraduate degree in 1998 and graduate degree in 2002 from the University of Pennsylvania.

Ajim Tamboli active positions

CompaniesPositionStart

Former positions of Ajim Tamboli

CompaniesPositionEnd
MONTE ROSA THERAPEUTICS, INC. Director of Finance/CFO 08/08/2023
Director of Finance/CFO 01/01/2020
Analyst-Equity 01/01/2019
Analyst-Equity 01/07/2013
Analyst-Equity 01/12/2009
See the detail of Ajim Tamboli's experience

Training of Ajim Tamboli

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Finance

Finance

Consumer Services

Finance

Health Technology

Finance

Finance

Commercial Services

Health Technology